Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, 19104, United States
Completed
NCT Number: NCT00880932
Warfarin and Non-Steroidal Anti-Inflammatory Drugs (NSAID) Customized Alert
The hypothesis is that a newly formatted electronic alert that requires the prescriber to pause and enter a specific "reason for override" on this alert, will cause prescribers in the intervention group to be significantly less likely to prescribe the combination of warfarin and NSAID than prescribers in the control group.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- All resident physicians (RP) and nurse practitioners (NP) involved in inpatient care at two hospitals of the University of Pennsylvania
Exclusion criteria
- None
Treatment and study plan
Electronic Alert
BehavioralPrimary outcomes
-
Decreased rate of prescription of the combination of warfarin and NSAID
Time frame: 17 months
Sponsors and collaborators
Lead sponsor
University of Pennsylvania
Other
Registry information
Official study title
The Effect of Customized Alerts Versus Generic Alerts for the Prescription of Warfarin and NSAID
Important dates
- Study start
- 2006
- Primary completion
- 2007
- Study completion
- 2007
- First posted
- Apr 14, 2009
- Registry last updated
- Apr 14, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.